GNH USA

Europe — EMA

Oczyesa (Octreotide)

G...

Request sourcing

1
Pack/s

What is Octreotide?

Octreotide, the active ingredient in Oczyesa, is a synthetic peptide analogue presented as a sterile solution for subcutaneous injection use. It is employed in the management of hormone‑secreting tumours and related complications in adult patients. GNH USA supplies Oczyesa as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres and oncology centres worldwide.

What is Octreotide used for?

Octreotide acts ​      ​  ​  ​  ​  ​  ​  ​   ​  ​    ​    ​     ​ •  ​  ​    ...   -  Acid       ....  ... .... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  - ... ... ... .... ... ... ... ... ...  - ... .... ...

What are the side effects of Octreotide?

Octreotide may  … ...

What precautions apply to Octreotide?

Octreotide  ...

What does Octreotide interact with?

Octre Requirements...

Frequently asked questions

What ...+
...
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Product details

Drug
Octreotide
Route
Subcutaneous Use
Manufacturer
Camurus Ab
Origin
EU

Related products